Τόμος 13 (1999) – Τεύχος 1 – Άρθρο 2 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 13 (1999) – Issue 1 – Article 2 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Institute of Biological Research and Biotechnology, The National Hellenic Research Foundation, 48 Vas. Constantinou Avenue, 116 35 Athens, Greece

pharmakonpress[at]pharmakonpress[.]gr

2.  Goodford, P.J.: Computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J. Med. Chem. 28: 849-857 (1985)

3.  Von Itzstein, M., Colman, P.: Design and synthesis of carbohydrate-based inhibitors of protein-carbohydrate interactions. Curr. Opin. Struct. Biol. 6: 703-709 (1996)

4.  Von itzstein, M., Thomson, R.J.: Sialic acids and sialic acid-recognising proteins: drug discovery targets and potential glycopharmaceuticals. Cur. Med. Chem. 4: 185- 210 (1997)

5.  Melnick, M., Reich, S.H., Lewis, K.K., Mitchell, L.J. Jr., Nguyen, D., Trippe, A.J., Dawson, H., Davies, J.F. II, Appelt, K., Wu, B.W. et al.: Bistertiary amide inhibitors of the HIV-1 protease generated via protein structure-based iterative design. J. Med. Chem. 39: 2795-2811 (1996)

6.  Thaisrivongs, S., Romero, D.L., Tommasi, R.A., Jana- kiraman, M.N., Strohbach, J.W., Turner, S.R., Biles, C., Morge, R.R., Johnson, P.D., Aristoff, P.A. et ai: Structure-based design of HIV protease inhibitors: 5,6-dihydro-4-hydroxy-2-pyrones as effective, nonpeptidic inhibitors. J. Med. Chem. 39: 4630-4642 (1996)

7.   Skulnick, H.I., Johnson, P.D., Aristoff, P.A., Morris, J.K., Lovasz, K.D., Howe, W.J., Watenpaugh, K.D., Janakiraman, M.N., Anderson, D.J., Reischer, R.J. et al: Structure-based design of nonpeptidic HIV protease inhibitors: the sulfonamide-substituted cyclooctylpyranones. J. Med Chem. 40: 1149-1164 (1997)

8.  Varney, M.D., Palmer, C.L., Romines, W.H. Ill, Boritzki, T., Margosiak, S.A., Almassy, R., Janson, C.A., Bartlett, C., Howland, E.J., Ferre, R.: Protein structure- based design, synthesis, and biological evaluation of 5- thia-2,6-diamino-4(3H)-oxopyrimidines: potent inhibitors of glycinamide ribonucleotide transformylase with potent cell growth inhibition. J. Med. Chem. 40: 2502-2524 (1997)

9.  Singh. J., Dobrusin, E.M., Fry, D.W., Haske, T„ Whitty, A., McNamara, D.J.: Structure-based design of a potent, selective, and irreversible inhibitor of the catalytic domain of the erbB receptor subfamily of protein tyrosine kinases. J. Med. Chem. 40: 1130-1135 (1997)

10.            Strynadka, N.C.J., Martin, R., Jensen, S.E., Gold, M., Jones, J.B.: Structure-based design of a potent transition state analogue for TEM-1 β-lactamase. Nature Struct. Biol. 3: 688-695 (1996)

11. Tucker, T.J., Lumma, W.C., Mulichak, A.M., Chen, Z., Naylor-Olsen, A.M., Lewis, S.D., Lucas, R., Freidinger, R.M., Kuo, L.C.: Design of highly potent noncovalent thrombin inhibitors that utilize a novel lipophilic binding pocket in the thrombin active site. J. Med. Chem. 40: 830-832 (1997)

12.            Jones, T.R., Webber, S.E., Varney, M.D., Reddy, M.R., Lewis, K.K., Kathardekar, V., Mazdiyasni, H., Deal, J., Nguyen, D., Welsh, K.M. et al: Structure-based design of substituted diphenyl sulfones and sulfoxides as lipophilic inhibitors of thymidylate synthase. J. Med. Chem. 40: 677-683 (1997)

13.            Mandrup-Poulsen, T.: Recent advances. Diabetes. BMJ 316: 1221-1225 (1998)

14.            Scheen, A.J.: Drug treatment of non-insulin-dependent diabetes mellitus in the 1990s. Achievements and future developments. Drugs 54: 355-368 (1997)

15.            Newgard, C.B., Hwang, P.K., Fletterick, R.J.: The family of glycogen phosphorylases: structure and function. Crit. Rev. Biochem. Mot. Biol. 24: 69-99 (1989)

16.            Krebs, E.G., Fischer, E.H.: The phosphorylase b to a converting enzyme of rabbit skeletal muscle. Biochim. Biophys. Acta 20: 150-157 (1956)

17. Dent, P., Lavoine, A., Nakielny, S., Caudwell, F.B., Watt, P., Cohen, P.: The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle. Nature 348: 302-308 (1990)

18.            Alemany, S., Cohen, P.: Phosphorylase a is an allosteric inhibitor of the glycogen and microsomal forms of rat hepatic protein phosphatase-1. FEBS Lett. 198: 194-202 (1986)

19.            Wera, S., Bollen, M., Stalmans, W.: Purification and characterization of the glycogen-bound protein phosphatase from rat liver. J. Biol. Chem. 266: 339-345 (1991)

20.            Bollen, M., Stalmans, W.: The structure, role, and regulation of type-1 protein phosphatases. Crit. Rev. Biochem. Mol. Biol. 27: 227-281 (1992)

21.            Monod, J., Wyman, J., Changeux, J.-P.: On the nature of allosteric transitions: a plausible model. J. Mol. Biol. 12: 88-118 (1965)

22.            Johnson, L.N., Hajdu, J. Achanya, K.R., Stuart, D.I., McLaughlin, P.J., Oikonomakos, N.G., Barford, D.: Glycogen phosphorylase b. In: Alosteric Enzymes (Herve, G., ed.), pp. 81-127, CRC Press, Boca Raton, Florida (1989)

23.            Johnson, L.N.: Glycogen phosphorylase: control by phosphorylation and allosteric effectors. FASEB J. 6: 2274-2282 (1992)

24.            Oikonomakos, N.G., Acharya, K.R., Johnson, L.N.: Rabbit muscle glycogen phosphorylase b : structural basis of activation and catalysis. In Post-Translational Modifica¬tion of Proteins (Harding, J.J. and Crabbe, M.J.C., Eds.), pp. 81-151, CRC Press, Boca Raton, Florida, 1992

25.            Martin, J.L., Veluraja, Κ., Johnson, L.N., Fleet, G.W.J., Ramsden, N.G., Bruce, I., Orchard, M., Oikonomakos, N.G., Papageorgiou, A.C., Leonidas, D.D., Tsitoura, H.S.: Glucose analogue inhibitors of glycogen phosphorylase: the design of potential drugs for diabetes. Biochemistry 30: 10101-10116 (1991)

26.            Kasvinsky, P.J., Shechosky, S., Fletterick, R.J.: Synergistic regulation of phosphorylase a by glucose and caffeine. J. Biol. Chem. 253: 9102-9106 (1978)

27.            Sprang, S.R., Goldsmith, E.J., Fletterick, R.J., Withers, S.G., Madsen, N.B.: Catalytic site of glycogen phosphorylase: structure of the T state and specificity for a-D- glucose. Biochemistry 21: 5364-5371 (1982)

28.            Kasvinsky, P.J., Fletterick. R.J., Madsen, N.B..: Regulation of the dephosphorylation of glycogen phosphorylase α and glycogen synthase b by glucose and caffeine in isolated hepatocytes. Can. J. Biochem. 59: 387-395 (1981)

29.            Ercan-Fang, N., Nuttall, F.Q.: The effect of caffeine and caffeine analogs on rat liver phosphorylase activity. J. Pharmacol. Exp. Ther. 280: 1312-1318 (1997)

30.            Helmreich, E.J.M., Cori, C.F.: The role of adenylic acid in the activity of phosphorylase. Proc. Nath Acad. Sci. USA 51: 131-138 (1964)

31.            Fischer, E.H., Krebs, E.G.: Muscle phosphorylase b. Methods Enzymol. 5: 369-373 (1962)

32.            Cohen P.: The subunit structure of rabbit-skeletal-muscle phosphorylase kinase, and the molecular basis of its activation reactions. Eur. J. Biochem. 34: 1-14 (1973)

33.            Owen, D.J., Papageorgiou, A.C., Garman, E.F., Noble, M.E.M., Johnson, L.N.: Expression, purification and crys-tallisation of phosphorylase kinase catalytic domain. J. Mot. Biol. 246: 374-381

34.            Melpidou, A.E., Oikonomakos, N.G.: The effects of glucose-6-phosphate on the catalytic and structural properties of glycogen phosphorylase a. FEBS Lett. 154: 105- 110 (1983)

35.            Kastenschmidt, L.L., Kastenschmidt, J., Helmreich, E.: Subunit interactions and their relationship to the allosteric properties of rabbit skeletal muscle phosphorylase b. Biochemistry 7: 3590-3608 (1968)

36.            Fiske, C.H., Subbarow, V.: The colorimetric determination of phosphorous. J. Biol. Chem. 66: 375-400 (1925)

37.            Leatherbarrow, R.J.: CraFtt Version 3.0. Erithakus Software, Staines, UK (1992)

38.            Oikonomakos, N.G., Melpidou, A.E., Johnson, L.N.: Crystallization of pig skeletal phosphorylase b. Purification, physical and catalytic characterization. Biochim. Biophys. Acta 832: 248-256 (1985)

39.            Kabsch, W.J.: Automatic-indexing of rotation diffraction patterns. J. Appl. Crystailogr. 21: 67-71 (1988)

40.            Kabsch, W.J.: Evaluation of single crystal X-ray diffraction data for a position sensitive detector. J. Appl. Crystallogr. 21: 916-924 (1988)

41.            Collaborative Computational Project, Number 4. The CCP4 Suite: Programs for Protein Crystallography. Acta Crystallogr. (Sect. D) 50: 760-763 (1994)

42.            Fletterick, R.J., Sygusch, J., Murray, N., Madsen, N.B., Johnson, L.N.: Low-resolution structure of the glycogen phosphorylase a monomer and comparison with phosphorylase b. J. Mol. Biol. 103: 1-13 (1976)

43.            Otwinowski Z.: DENZO. Data collection and Processing, DL/SC1/R34, SERC Laboratory, Daresbury, Warrington, U.K. (1993)

44.            Brunger, A.T.: X-PLOR Version 3.1. A System for X- ray Crystallography and NMR, Yale University Press, New Haven and London (1992)

45.            Brunger, A.T.: X-PLOR Version 3.8. Dept, of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT (1996)

46.            Zographos, S.E., Oikonomakos, N.G., Tsitsanou, K.E., Leonidas. D.D., Chrysina, E.D., Skamnaki, V.T., Bischoff, H., Goldmann, S., Watson, K.A., Johnson, L.N.: The structure of glycogen phosphorylase b with an alkyl- dihydropyridine-dicarboxylic acid compound, a novel and potent inhibitor. Structure 5: 1413-1425 (1997)

47.            Jones, T.A., Zou, J-Y., Cowan, S.W., Kjeldgaard, M.: Improved Methods for Building Protein Models in Electron Density Maps and the Location of Errors in these Models. Acta Cryst. A47: 110-119 (1991)

48.            Oikonomakos, N.G., Tsitsanou, K.E., Zographos, S.E., Skamnaki, V.T.: Allosteric inhibition of glycogen phosphorylase a by the potential antidiabetic drug (-)3-isopropyl 4-(2-ch1orophenyl)-1,4-dihydro-1-ethyl-2-methyl- pyridine-3,5,6-tricarboxylate. Submitted for publication.

49.            Oikonomakos, N.G., Kontou, M., Zographos, S.E., Watson, K.A., Johnson, L.N., Btchard, C.J.F., Fleet, G.W.J., Acharya, K.R.: N-acetyl-β-D-glucopyranosylamine: a potent T state inhibitor of glycogen phosphorylase. A comparison with α-D-glucose. Protein Sci. 4: 2469-2477 (1995)

50.            Watson, K.A., Mitchell, E.P., Johnson, L.N., Cruciani, G., Son, J.C., Bichard, C.J.F., Fleet, G.W.J., Oikonomakos, N.G., Kontou, M., Zographos, S.E.: Glucose analogue inhibitors of glycogen phosphorylase: From crystallographic analysis to drug prediction using GRID force-field and GOLPE variable selection. Acta Crystailogr. D. 51: 458-472 (1995)

51.            Board, M., Bollen, M., Stalmans, W., Kim, Y., Fleet, G.W.J., Johnson, L.N.: Effects of novel analogues of D- glucose on glycogen phosphorylase activities in crude extracts of liver and skeletal muscle. Eur. J. Biochem. 228: 753-761 (1995)

52.            Board, M., Bollen, M., Stalmans, W., Kim, Y., Fleet, G.W.J., Johnson, L.N.: Effects of a C1 substituted analogue on the activation states of glycogen synthase and qlycogen phosphorylase in rat hepatocytes. Biochem J. 311: 845-852 (1995)

53.            Board, M., Johnson, L.N.: Effects of N-acetyl-b-D- glucopyranosylamine on glycogen metabolism in isolated hepatocytes. Diabet. Res. 28: 95-109 (1995)

54.            Carabaza, A., Ciudad, C.J., Baque, S., Guinovart, J.J.: Glucose has to be phosphorylated to activate glycogen synthase, but not to inactivate glycogen phosphorylase in hepatocytes. FEBS Lett. 296: 211-214 (1992)

55.            Massilon, D., Bollen, M., De Wulf, H., Overloop, K., Vanstapel, F., Van Hecke, P., Stalmans, W.: Demonstration of a glycogen/glucose 1-phosphate cycle in hepatocytes from fasted rats. Selective inactivation of phosphorylase by 2-deoxy, 2-fluoro-a-D-glucosyl fluoride. J. Biol. Chem. 270: 19351-19356 (1995)

56.            Board, M.: N-acetyl-beta-D-glucopyranosylamine-6- phosphate is a specific inhibitor of glycogen-bound protein phosphatase I. Biochem. J. 328: 695-700 (1997)

57.            Blériot, Y., Smelt, K.H., Cadefau, J., Bollen, M., Stal-mans. W., Biggadike, Κ., Johnson, L.N., Oikonomakos, N.G., Lane, A.L., Crook, S., Watkin, D.J., Fleet, G.W.J.: 7-Carbon mimics of D-glucose and L-fucose: Activation by 6R-, and Inactivation by 6S, 6C-Methylglucose of glycogen synthase: Inhibition of Glucokinase and/or Glucose-6-phosphatase. Tetrahedron Lett. 37, 7155-7158 (1996)

58.            Fonne-Pfister, R., Chemla, P., Ward, E., Giradet, M., Kreuz, K.E., Honzatko, R.B., Fromm, H.J., Schar, H.-P., Grutter, M.G., Cowan-Jacob, S.W.: The mode of action and the structure of a herbicide in complex with its target: binding of activated hydantocidin to the feedback regulation site of adenylosuccinate synthetase. Proc. Natl. Acad. Sci. USA 93: 9431-9436 (1996)

59.            Bichard, C.J.F., Mitchell, E.P., Wormald, M.R., Watson, K.A., Johnson, L.N., Zographos, S.E., Koutra, D.D., Oikonomakos, N.G., Fleet, G.W.J.: Potent inhibition of glycogen phosphorylase by a spirohydantoin of glucopyranose: first pyranose analogue of hydantocidin. Tetrahedron Lett. 36: 2145-2148 (1995)

60.            Krulle, T.M., de la Fuente, C„ Watson, K.A., Gregoriou, M., Johnson, L.N., Tsitsanou, K.E., Zographos, S.E., Oikonomakos, N.G., Fleet, G.W.J.: Stereospecific synthesis of spirohydantoins of β-glucopyranose: Inhibitors of glycogen phosphorylase. Synlett,, 211-213 (1997)

61.            Gregoriou, M., Noble,      Watson, K.A., Garman, E.F.,  Krulle, T.M., Fuente, C., Fleet, G.W.J., Oikonomakos, N.G., Johnson, L.N.: The structure of a glycogen phosphorylase spirohydantoin complex at 1.8 A resolution and 100 K: The role of the water structure and its contribution to binding. Protein Sci. 7: 915-927 (1998)

62.            De la Fuente, O., Krulle, T.M., Watson, K.A., Gregoriou, M., Johnson, L.N., Tsitsanou, K.E., Zographos, S.E., Oikonomakos, N.G., Fleet, G.W.J.: Glucopyranose Spirohydantoins: Specific inhibitors of Glycogen Phosphorylase. Synlett: 485-487 (1997)

63.            Brandstetter, T.W., Wormald, M.R., Dwek, R.A., Butters, T.D., Platt, F.M., Tsitsanou, K.E., Zographos,

S.E., Oikonomakos, N.G., Fleet, G.W.J.: A galactopyranose analogue of hydantocidin. Tetrahedron Asymm. 7: 157-170 (1996)

64.            Brandstetter, T.W., de la Fuente, C., Kim, Y.-H., Crook, S., Lüley, P.M.Q., Watkin, D.J., Tsitsanou, K.E., Zographos, S.E., Chrysina, E.D., Oikonomakos, N.G., Johnson, L.N., Fleet, G.W.J.: Glucofuranose analogues of hydantocidin. Tetrahedron 52: 10721-10736 (1996)

65.            Watson, K.A., Tsitsanou, K.E., Gregoriou, M., Zographos, S.E., Skamnaki, V.T., Oikonomakos, N.G., Fleet, G.W.J., Johnson, L.N.: Desolvation effects and water- mediated interactions characterise inhibitor binding in glycogen phosphorylase. Submitted for publication.

66.            Krulle, T.M., Watson, K.A., Gregoriou, M., Johnson, L.N., Crook, S., Watkin, D.J., Griffiths, R.C., Nasj, R.J., Tsitsanou, K.E., Zographos, S.E., Oikonomakos, N.G., Fleet, G.W.J.: Specific inhibition of glycogen phosphorylase by a spirodiketopiperazine at the anomeric position of glucopyranose. Tetrahedron Lett. 36: 8291-8294 (1995)

67.            Tsitsanou, K.E., Oikonomakos, N.G., Zographos, S.E., Skamnaki, V.T., Gregoriou, M., Watson, K.A., Johnson, L.N., Fleet, G.W.J.: The effect of most commonly used cryoprotectants on the activity and structure of glycogen phosphorylase b. Protein Sci., in press (1999)

68.            Krulle, T.M., de la Fuente, C., Pickering, L., Aplin, R.T., Tsitsanou, K.E., Zographos, S.E., Oikonomakos, N.G., Nash, R.J., Griffiths, R.C., Fleet, G.W.J.: Triazole carboxylic acids as anionic sugar mimics? Inhibition of glycogen phosphorylase by a glucotriazole carboxylate. Tetrahedron Asymm. 8: 3807-3820 (1997)

69.            Mitchell, E.P., Withers, S.G., Ermert, P., Vasella, A.T., Garman, E.F., Oikonomakos, N.G., Johnson, L.N.: Ternary complex crystal structures of glycogen phosphorylase with the transition state analogue Nojirimycin Tetrazole and phosphate in the T and R states. Biochemistry 35: 7341-7355 (1996)

70.            Goldmann, S., Ahr, H.J., Puls, W., Bischoff, H., Petzinna, D., Schlossmann, Κ., Bender, J.: Dihydropyridine compounds and their use in reducing blood sugar. US Patent 4,786,641 Bayer AG (1988)

71. Burley, S.K., Petsko, G.A.: Weakly polar interactions in proteins. Adv. Protein Chem. 39: 125-189 (1988)

72.            Johnson, L.N., Martin, J.L., Acharya, K.R., Barford, D., Oikonomakos, N.G.: The refined crystal structure of the glycogen phosphorylase-glucose-6-phosphate complex. J. Mol. Biol. 232: 253-267 (1993)

73.            Battersby, M.K., Radda, G.K.: The stereospecificity of the glucose-6-phosphate binding site of glycogen phosphorylase. Biochemistry 18: 3774-3780 (1976)

74.            Wang, J.H., Tu, J.I., Lo, F.M.: Effect of glucose 6- phosphate on the nucleotide site of glycogen phosphorylase b. J. Biol. Chem. 245: 3115-3121 (1970)

75.            Leonidas, D.D., Oikonomakos, N.G., Papageorgiou, A.C., Xenakis, A., Cazianis, C.T., Bern, F.: The ammonium sulphate activation of phosphorylase b. FEBS Lett. 261: 23-27 (1990)

76.            Oikonomakos, N.G., Zographos, S.E., Johnson, L.N., Papageorgiou, A.C., Acharya, K.R.: The binding of 2-deoxy-glucose-6-phosphate to glycogen phosphorylase b: kinetic and crystallographic studies. J. Mol. Biol. 254: 900- 917 (1995)

pharmakonpress[at]pharmakonpress[.]gr

pharmakonpress[at]pharmakonpress[.]gr